Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, Milano, 20133, Italy
Location status: Recruiting
NCT Number: NCT04880356
General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Milan, Milano, 20133, Italy
Location status: Recruiting
The study provides a collection of retrospective data from adult patients with ultra-rare inherited neurological diseases followed at "Carlo Besta" Neurological Institute from 1st January 2004 until March 2021. Further, prospective data will be collected starting from March 2021 (date of protocol approval) and spanning the next ten years. Normal clinical practice will be followed for collection of the prospective data. Follow-up assessment will be performed at least once a year to evaluate the disease course. Based on their clinical manifestations, patients will be assessed by using quantitative functional tests (clinimetric tests such as Timed Up and Go Test) and traditional ordinal scales (such as the scale for the assessment and rating of ataxia (SARA). Moreover, a varying of laboratory and instrumental tests (e.g., neuroimaging, neurophysiological investigations, etc.) will be used according to clinical practice in selected patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
collection of retrospective and prospective data from adult patients with ultra-rare inherited neurological diseases
Time frame: 10 years
Repeated Montreal Cognitive Assessment (MoCA) letter F fluency subtest
Time frame: 10 years
Repeated SARA (Scale for the Assessment and Rating Ataxia) stance subtask, ambulation index (AI) and Timed Up and Go (TUG) test
Time frame: 10 years
Repeated ONLS (Overall Neuropathy Limitation Scale) arm scale
Time frame: 10 years
Repeated NP-C mDRS (Niemann-Pick type C modified disability rating scale) swallowing scale
Time frame: 10 years
Repeated NP-C mDRS language scale
Time frame: 10 years
Repeated AADS (Adult Adrenoleukodystrophy Disability Score) Bladder function scale
Time frame: 10 years
Repeated assessment of presence or absence of sleep disturbances
Time frame: 10 years
Repeated EuroQol-5D-5L (EQ-5D-5L) questionnaire
Contact information is provided by the study sponsor or research team.
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Other
Clinical, Instrumental and Laboratory Data Collection of Subjects with Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05386134
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Disease
Toronto, Ontario, Canada
View Trial DetailsNCT03568630
Chronic Disease, Chronic Pancreatitis
Omaha, Nebraska, United States
View Trial DetailsNCT03047369
4H Syndrome, ADLD
Los Angeles, California, United States
View Trial DetailsNCT02699190
4H Syndrome, ADLD
Philadelphia, Pennsylvania, United States
View Trial Details